Skip Navigation

European Heart Journal 2000 21(19):1607-1613; doi:10.1053/euhj.2000.2127
Copyright © 2000 by the European Society of Cardiology.
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow References
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (18)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Smith, F.B
Right arrow Articles by Hau, C.M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Smith, F.B
Right arrow Articles by Hau, C.M
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Tissue plasminogen activator and leucocyte elastase as predictors of cardiovascular events in subjects with angina pectoris: Edinburgh Artery Study

F.B Smitha,f1, F.G.R Fowkesa, A Rumleyb, A.J Leea, G.D.O Loweb and C.M Haua

a Wolfson Unit for Prevention of Peripheral Vascular Diseases, Public Health Sciences, University of Edinburgh Medical School, U.K.
b Haemostasis Thrombosis and Vascular Medicine Unit, University Department of Medicine, Glasgow Royal Infirmary, U.K.

revised January 14, 2000; accepted January 19, 2000

Abstract

Aims To evaluate the relationship between haemostatic and rheological factors and cardiovascular outcome in subjects with angina pectoris in the general population.

Methods and Results Two hundred and seven men and women aged 55–74 had evidence of angina at baseline. Sixty-seven (32·3%) had a fatal or non-fatal cardiovascular event during follow-up. Median levels of tissue plasminogen activator antigen and leucocyte elastase were higher in the event group compared with the no event group (10·0ng.ml–1vs 7·2ng.ml–1;P≤0·001, and 40·3ng.ml–1vs 31·0ng.ml–1;P≤0·01, respectively). Whole blood viscosity was also significantly higher in the event group than in the no event group (3·80mPa.s vs 3·53mPa.s;P≤0·05). After adjusting for age and sex, unit increases in both tissue plasminogen activator antigen and leucocyte elastase levels were significantly associated with an increased risk of a cardiovascular event. These associations remained after further adjusting for cardiovascular risk factors and baseline myocardial infarction. The relative risks were 2·07 (95% CI, 1·30–3·45;P≤0·01) for tissue plasminogen activator antigen and 1·95 (95% CI, 1·12–3·50;P≤0·05) for leucocyte elastase.

Conclusion Disturbed fibrinolysis and activation of leucocytes may be implicated in the development of thrombotic cardiovascular events in subjects with angina pectoris in the general population.

Key Words: Angina pectoris, cardiovascular events, tissue plasminogen activator, leucocyte elastase

f1 Correspondence: Dr Felicity Smith, Wolfson Unit for Prevention of Peripheral Vascular Diseases, Public Health Sciences, University of Edinburgh, Medical School, Teviot Place, Edinburgh EH8 9AG, U.K.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 CirculationHome page
H. Hemingway, C. Langenberg, J. Damant, C. Frost, K. Pyorala, and E. Barrett-Connor
Prevalence of Angina in Women Versus Men: A Systematic Review and Meta-Analysis of International Variations Across 31 Countries
Circulation, March 25, 2008; 117(12): 1526 - 1536.
[Abstract] [Full Text] [PDF]

Home page
 CLIN APPL THROMB HEMOSTHome page
R. Lo Presti, M. Montana, G. Amodeo, E. Incalcaterra, and G. Caimi
Persistence of High Plasma Elastase Level in Young Subjects With Acute Myocardial Infarction
Clinical and Applied Thrombosis/Hemostasis, April 1, 2007; 13(2): 224 - 225.
[PDF]

Home page
 Eur Heart JHome page
G.D.O. Lowe, J. Danesh, S. Lewington, M. Walker, L. Lennon, A. Thomson, A. Rumley, and P.H. Whincup
Tissue plasminogen activator antigen and coronary heart disease: Prospective study and meta-analysis
Eur. Heart J., February 1, 2004; 25(3): 252 - 259.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
V. Fonseca, C. Desouza, S. Asnani, and I. Jialal
Nontraditional Risk Factors for Cardiovascular Disease in Diabetes
Endocr. Rev., February 1, 2004; 25(1): 153 - 175.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
P. Fernandez, P. Marco, F. Marin, V. Roldan, and F. Sogorb
The role of tissue plasminogen activator on the progression of the coronary disease
Eur. Heart J., January 1, 2002; 23(1): 88 - 88.
[Full Text] [PDF]

Home page
 Eur Heart JHome page
P.J. Grant
The Edinburgh Artery Study: is lytic activity bad for the heart?
Eur. Heart J., October 1, 2000; 21(19): 1566 - 1567.
[PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.